LRP1 and glioblastoma: Angiopep-2 (ANG2), a synthetic peptidederived from the Kunitz domain of the LRP-1 ligands, demonstrateda high BBB transcytosis efficacy by targeting LRP-1.33,34 Several studies have shown that the functionalization of NPs withANG2 enhances BBB penetration and GBM cell targeting.